CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
暂无分享，去创建一个
S. Robinson | M. Walton | K. Boxall | G. Aherne | M. Garrett | M. Valenti | A. K. de Haven Brandon | Paul D. Eve | F. Raynaud | S. Eccles | I. Collins | A. Hayes | G. Box | J. Reader | Y. Jamin | A. Hallsworth | Elizabeth L. Smith | M. Lainchbury | T. Matthews | L. Chesler | Thomas P Matthews